stoxline Quote Chart Rank Option Currency Glossary
  
Mainz Biomed B.V. (MYNZ)
6.04  -0.49 (-7.5%)    02-14 16:00
Open: 6.48
High: 6.6
Volume: 448,930
  
Pre. Close: 6.53
Low: 5.97
Market Cap: 13(M)
Technical analysis
2025-02-14 4:49:58 PM
Short term     
Mid term     
Targets 6-month :  7.79 1-year :  9.57
Resists First :  6.67 Second :  8.19
Pivot price 6.66
Supports First :  4.19 Second :  3.49
MAs MA(5) :  7.02 MA(20) :  6.15
MA(100) :  2.95 MA(250) :  1.56
MACD MACD :  0.6 Signal :  0.6
%K %D K(14,3) :  60.4 D(3) :  73.8
RSI RSI(14): 50
52-week High :  8.19 Low :  0.18
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ MYNZ ] has closed above bottom band by 32.3%. Bollinger Bands are 36.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 6.61 - 6.66 6.66 - 6.7
Low: 5.87 - 5.92 5.92 - 5.96
Close: 5.97 - 6.05 6.05 - 6.11
Company Description

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.

Headline News

Mon, 27 Jan 2025
Mainz Biomed Regains Nasdaq Listing Compliance - TipRanks

Tue, 14 Jan 2025
Mainz Biomed B.V. Addresses Nasdaq Listing Compliance Issue - TipRanks

Thu, 19 Dec 2024
Mainz Biomed stock higher on Quest deal (MYNZ:NASDAQ) - Seeking Alpha

Wed, 18 Dec 2024
Mainz Biomed stock hits 52-week low at $4.3 amid sharp annual decline - Investing.com

Tue, 10 Dec 2024
Mainz Biomed stock hits 52-week low at $6.12 amid market challenges - Investing.com

Mon, 02 Dec 2024
Mainz Biomed announces 1-for-40 reverse stock split - Medical Buyer

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out -13 (M)
Shares Float 0 (M)
Held by Insiders 2.22e+006 (%)
Held by Institutions 2.209e+007 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 540960
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -44.41
Profit Margin 0 %
Operating Margin -1 %
Return on Assets (ttm) 883.2 %
Return on Equity (ttm) -99.3 %
Qtrly Rev. Growth 333.7 %
Gross Profit (p.s.) 123.33
Sales Per Share -3368.89
EBITDA (p.s.) 0
Qtrly Earnings Growth -2.159e+007 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value -0.14
Price to Sales -0.01
Price to Cash Flow 0
Stock Dividends
Dividend 41310
Forward Dividend 123200
Dividend Yield 683940%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android